TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $327,505 (100.0% shares, 0.0% debt)

Holdings (5)

HRTX HERON THERAPEUTICS INC 42.6%

Value ($000) $139,596 Shares 8,643,739 Est. Cost $13.92 Unrealized +12.7%

— LA JOLLA PHARMACEUTICAL CO 36.5%

Value ($000) $119,658 Shares 3,440,419 Est. Cost $16.25 Unrealized —

— IGNYTA INC 18.0%

Value ($000) $58,830 Shares 4,763,602 Est. Cost $6.25 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.6%

Value ($000) $8,396 Shares 90,215 Est. Cost $62.32 Unrealized +41.8%

— CYCLACEL PHARMACEUTICALS INC 0.3%

Value ($000) $1,025 Shares 559,900 Est. Cost $5.17 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	8,643,739	$139,596	42.6%	$13.92	+12.7%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	3,440,419	$119,658	36.5%	$16.25	—	COM	503459604
—	IGNYTA INC	4,763,602	$58,830	18.0%	$6.25	—	COM	451731103
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$8,396	2.6%	$62.32	+41.8%	COM	09061G101
—	CYCLACEL PHARMACEUTICALS INC	559,900	$1,025	0.3%	$5.17	—	COM	23254L405